Michael Abouyannis

1.8k total citations
18 papers, 217 citations indexed

About

Michael Abouyannis is a scholar working on Virology, Genetics and Infectious Diseases. According to data from OpenAlex, Michael Abouyannis has authored 18 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Virology, 7 papers in Genetics and 6 papers in Infectious Diseases. Recurrent topics in Michael Abouyannis's work include Venomous Animal Envenomation and Studies (7 papers), Rabies epidemiology and control (7 papers) and HIV/AIDS Research and Interventions (3 papers). Michael Abouyannis is often cited by papers focused on Venomous Animal Envenomation and Studies (7 papers), Rabies epidemiology and control (7 papers) and HIV/AIDS Research and Interventions (3 papers). Michael Abouyannis collaborates with scholars based in United Kingdom, United States and Malawi. Michael Abouyannis's co-authors include Lesley Roberts, David G. Lalloo, Nicholas R. Casewell, Joseph M. Lewis, Agnes Kiragga, Kathryn Haigh, Stephen Aston, Peter Hampshire, Mainga Hamaluba and Gareth Jones and has published in prestigious journals such as Clinical Infectious Diseases, AIDS and Thrombosis and Haemostasis.

In The Last Decade

Michael Abouyannis

17 papers receiving 210 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Abouyannis United Kingdom 10 78 77 69 40 36 18 217
Zaiyad Garba Habib Nigeria 10 74 0.9× 90 1.2× 46 0.7× 11 0.3× 31 0.9× 26 246
Michel Müller France 6 74 0.9× 22 0.3× 42 0.6× 141 3.5× 18 0.5× 18 286
Simone Vasilij Benatti Italy 7 86 1.1× 9 0.1× 173 2.5× 9 0.2× 63 1.8× 13 322
María José Sierra Moros Spain 8 16 0.2× 12 0.2× 53 0.8× 27 0.7× 89 2.5× 21 205
Nicole M Kopari United States 3 21 0.3× 7 0.1× 150 2.2× 17 0.4× 41 1.1× 10 312
Basma Abdi France 10 102 1.3× 9 0.1× 265 3.8× 8 0.2× 38 1.1× 30 325
R.H Haug 7 39 0.5× 9 0.1× 176 2.6× 13 0.3× 147 4.1× 19 289
Raquel Ron Spain 10 61 0.8× 7 0.1× 148 2.1× 8 0.2× 67 1.9× 24 261
Martin Tepper Canada 11 15 0.2× 13 0.2× 60 0.9× 18 0.5× 238 6.6× 30 391
Michael O’Shea United States 9 43 0.6× 19 0.2× 55 0.8× 162 4.0× 53 1.5× 12 341

Countries citing papers authored by Michael Abouyannis

Since Specialization
Citations

This map shows the geographic impact of Michael Abouyannis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Abouyannis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Abouyannis more than expected).

Fields of papers citing papers by Michael Abouyannis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Abouyannis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Abouyannis. The network helps show where Michael Abouyannis may publish in the future.

Co-authorship network of co-authors of Michael Abouyannis

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Abouyannis. A scholar is included among the top collaborators of Michael Abouyannis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Abouyannis. Michael Abouyannis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Laustsen, Andreas H., Melisa Bénard-Valle, Abdulrazaq G. Habib, et al.. (2025). Target product profiles for pan-Africa recombinant antivenoms against neurotoxic or hemotoxic and cytotoxic snakebite envenoming. PLoS neglected tropical diseases. 19(1). e0012833–e0012833. 2 indexed citations
3.
Abouyannis, Michael, Dianne Kitchen, Steve Kitchen, et al.. (2024). Handheld Point-of-Care Devices for Snakebite Coagulopathy: A Scoping Review. Thrombosis and Haemostasis. 125(5). 405–420. 1 indexed citations
4.
Abouyannis, Michael, Mwanamvua Boga, Amek Nyaguara, et al.. (2023). A long-term observational study of paediatric snakebite in Kilifi County, south-east Kenya. PLoS neglected tropical diseases. 17(7). e0010987–e0010987. 8 indexed citations
5.
Bickler, Philip E., Michael Abouyannis, Ashish Bhalla, & Matthew R. Lewin. (2023). Neuromuscular Weakness and Paralysis Produced by Snakebite Envenoming: Mechanisms and Proposed Standards for Clinical Assessment. Toxins. 15(1). 49–49. 13 indexed citations
6.
Lamb, Thomas, Michael Abouyannis, Sâmella Silva de Oliveira, et al.. (2021). The 20-minute whole blood clotting test (20WBCT) for snakebite coagulopathy—A systematic review and meta-analysis of diagnostic test accuracy. PLoS neglected tropical diseases. 15(8). e0009657–e0009657. 33 indexed citations
7.
Abouyannis, Michael, Dinesh Aggarwal, David G. Lalloo, et al.. (2021). Clinical outcomes and outcome measurement tools reported in randomised controlled trials of treatment for snakebite envenoming: A systematic review. PLoS neglected tropical diseases. 15(8). e0009589–e0009589. 15 indexed citations
8.
Nightingale, Rebecca, Nneka Nwosu, Tom Fletcher, et al.. (2020). Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service. BMJ Open Respiratory Research. 7(1). e000639–e000639. 43 indexed citations
9.
Lewis, Joseph M., et al.. (2019). Population Incidence and Mortality of Sepsis in an Urban African Setting, 2013–2016. Clinical Infectious Diseases. 71(10). 2547–2552. 13 indexed citations
10.
Abouyannis, Michael, et al.. (2014). Attitudes of Serodiscordant Couples Towards Antiretroviral-Based HIV Prevention Strategies in Kenya: A Qualitative Study. AIDS Patient Care and STDs. 29(1). 33–42. 8 indexed citations
11.
Abouyannis, Michael, et al.. (2014). Attitudes of serodiscordant couples towards antiretroviral‐based HIV prevention strategies in Kenya: a qualitative study. Journal of the International AIDS Society. 17(4S3). 19563–19563. 13 indexed citations
12.
Abouyannis, Michael, Russell Dacombe, Brian Faragher, et al.. (2014). Drug resistance ofMycobacterium tuberculosisin Malawi: a cross-sectional survey. Bulletin of the World Health Organization. 92(11). 798–806. 10 indexed citations
13.
Abouyannis, Michael, et al.. (2014). Which clinical parameters predict a positive CSF diagnosis of meningitis in a population with high HIV prevalence?. Southern African Journal of HIV Medicine. 15(2). 50–54. 3 indexed citations
14.
Abouyannis, Michael, Russell Dacombe, Brian Faragher, et al.. (2014). Resistencia medicamentosa a la Mycobacterium tuberculosis en Malawi: una encuesta transversal. 92(11). 798–806. 7 indexed citations
15.
Abouyannis, Michael, et al.. (2014). Which clinical parameters predict a positive CSF diagnosis of meningitis in a population with high HIV prevalence?. Southern African Journal of HIV Medicine. 15(2). 50–50.
16.
Fong, Alan Yean Yip, et al.. (2013). Bleeding events and associated factors in a cohort of adult patients taking warfarin in Sarawak, Malaysia. Journal of Thrombosis and Thrombolysis. 38(2). 226–234. 6 indexed citations
17.
Abouyannis, Michael, et al.. (2012). Essential therapeutics skills required of junior doctors. Perspectives on Medical Education. 1(5-6). 225–236. 10 indexed citations
18.
Abouyannis, Michael, Joris Menten, Agnes Kiragga, et al.. (2011). Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan Africa. AIDS. 25(13). 1627–1635. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026